DHI GROUP, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that DHI GROUP, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $127.83M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $141.93M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $151.88M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $149.68M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $119.90M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $111.17M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $117.27M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $161.57M | Feb 10, 2021 |
| FY2014 | Dec 31, 2014 | $67.77M | Feb 10, 2015 |
| FY2014 | Sep 30, 2014 | $67.62M | Feb 10, 2015 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $33.75M | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | $30.76M | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | $28.72M | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | $26.68M | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | $27.04M | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | $27.15M | Feb 11, 2022 |
| FY2021 | Jun 30, 2020 | $27.60M | Feb 11, 2022 |
| FY2021 | Mar 31, 2020 | $29.39M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $37.72M | Feb 10, 2021 |
| FY2020 | Sep 30, 2019 | $37.18M | Feb 10, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $65.06M | Feb 10, 2016 |
| FY2015 | Sep 30, 2015 | $65.14M | Feb 10, 2016 |
| FY2015 | Jun 30, 2015 | $65.80M | Feb 10, 2016 |
| FY2015 | Mar 31, 2015 | $63.77M | Feb 10, 2016 |
| FY2015 | Dec 31, 2014 | $67.77M | Feb 10, 2016 |
| FY2015 | Sep 30, 2014 | $67.62M | Feb 10, 2016 |
| FY2015 | Jun 30, 2014 | $66.54M | Feb 10, 2016 |
| FY2015 | Mar 31, 2014 | $60.69M | Feb 10, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($13.51M) | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $253.0K | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $3.49M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $4.18M | Feb 12, 2025 |
| FY2021 | Dec 31, 2021 | $232.0K | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | ($2.43M) | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | ($30.21M) | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | $2.67M | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | $2.00M | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | ($27.32M) | Feb 11, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($11.37M) | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $6.33M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $6.29M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $5.56M | Feb 12, 2025 |
| FY2021 | Dec 31, 2021 | $159.0K | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | ($2.22M) | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | $488.0K | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | ($184.0K) | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | $1.00M | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | ($28.48M) | Feb 11, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.84M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $18.88M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $17.78M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $17.67M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $16.02M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $14.89M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $14.70M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $20.21M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $24.98M | Feb 6, 2020 |
| FY2015 | Dec 31, 2015 | $29.86M | Feb 10, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.10M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $21.05M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $21.35M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $36.04M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $28.58M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $18.68M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $22.92M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $14.92M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $34.41M | Feb 6, 2020 |
| FY2015 | Dec 31, 2015 | $60.81M | Feb 10, 2016 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.31M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $13.93M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $20.25M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $17.98M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $14.31M | Feb 8, 2024 |
| FY2022 | Dec 31, 2020 | $16.10M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $14.19M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $10.05M | Feb 10, 2021 |
| FY2019 | Dec 31, 2017 | $13.22M | Feb 6, 2020 |
| FY2015 | Dec 31, 2015 | $9.08M | Feb 10, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $188.24M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $221.37M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $225.20M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $226.70M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $221.58M | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $240.99M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $278.32M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $258.39M | Feb 6, 2020 |
| FY2019 | Dec 31, 2017 | $295.72M | Feb 6, 2020 |
| FY2015 | Dec 31, 2015 | $370.50M | Feb 10, 2016 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $93.74M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $107.05M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $117.66M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $120.47M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $105.22M | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $113.42M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $117.13M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $113.03M | Feb 6, 2020 |
| FY2015 | Dec 31, 2015 | $231.89M | Feb 10, 2016 |
| FY2015 | Dec 31, 2014 | $246.16M | Feb 10, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $94.51M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $114.33M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $107.54M | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | $106.24M | Feb 12, 2026 |
| FY2022 | Dec 31, 2021 | $116.36M | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $127.57M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $161.20M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $145.36M | Feb 6, 2020 |
| FY2015 | Dec 31, 2015 | $138.61M | Feb 10, 2016 |
| FY2015 | Dec 31, 2014 | $177.80M | Feb 10, 2016 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $120.61M | Feb 12, 2026 |
| FY2025 | Jan 13, 2025 | $128.10M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $128.10M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $128.10M | Feb 12, 2026 |
| FY2022 | Dec 31, 2022 | $128.10M | Feb 10, 2023 |
| FY2022 | Dec 31, 2021 | $128.10M | Feb 10, 2023 |
| FY2022 | Dec 31, 2020 | $128.10M | Feb 10, 2023 |
| FY2022 | Jan 1, 2020 | $150.71M | Feb 10, 2023 |
| FY2020 | Dec 31, 2019 | $156.06M | Feb 10, 2021 |
| FY2020 | Dec 31, 2018 | $153.97M | Feb 10, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.97M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $32.48M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $32.23M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $28.41M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $24.23M | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $53.97M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $83.99M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $71.44M | Feb 6, 2020 |
| FY2015 | Dec 31, 2015 | $49.48M | Feb 10, 2016 |
| FY2015 | Dec 31, 2014 | $60.44M | Feb 10, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.91M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $3.70M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $4.21M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $3.01M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | $1.54M | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $4.54M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $5.38M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $6.47M | Feb 6, 2020 |
| FY2015 | Dec 31, 2015 | $34.05M | Feb 10, 2016 |
| FY2015 | Dec 31, 2014 | $26.78M | Feb 10, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $30.00M | Feb 10, 2023 |
| FY2022 | Dec 31, 2021 | $22.73M | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $19.58M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $9.44M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | $17.29M | Feb 6, 2020 |
| FY2015 | Dec 31, 2015 | $101.00M | Feb 10, 2016 |
| FY2015 | Dec 31, 2014 | $110.50M | Feb 10, 2016 |
| FY2013 | Dec 31, 2013 | $50.00M | Feb 14, 2014 |
| FY2013 | Dec 31, 2010 | $0 | Feb 14, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 12, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 11, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 12, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 11, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 44.46M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 48.22M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 46.88M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 47.37M | Feb 8, 2024 |
| FY2022 | Dec 31, 2021 | 48.76M | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | 51.22M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | 53.92M | Feb 10, 2021 |
| FY2019 | Dec 31, 2018 | 53.40M | Feb 6, 2020 |
| FY2015 | Dec 31, 2015 | 52.62M | Feb 10, 2016 |
| FY2015 | Dec 31, 2014 | 54.14M | Feb 10, 2016 |